Ultra-processed foods and food additives in gut health and disease.
Kevin Whelan, Aaron S Bancil, James O Lindsay...
https://pubmed.ncbi.nlm.nih.gov/38388570/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-09-11
120
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are investigating how everyday exposure to common environmental substances affects health, focusing on allergic and inflammatory conditions. The study aims to understand the links between lifestyle exposures, inflammation, and disease by examining the effects of typical skin and hair products, processed foods, and air pollutants compared with cleaner, natural environments. This interventional study involves healthy adults aged 18 to 80 years and is sponsored by the National Institute of Allergy and Infectious Diseases NIAID. Participants will have two separate 7-day inpatient stays spaced 4 to 6 weeks apart. One stay involves a pure environment with filtered air, unprocessed foods, and toxin-free personal care products, while the other exposes participants to common environmental chemicals affecting the skin, gut, or airway. In the first stage, participants are assigned to one of three cohorts targeting skin, gastrointestinal, or airway exposures, with crossover between common and pure environments. The second stage involves combined exposures to all three systems. During stays, participants will adhere strictly to provided diets and personal care products. Throughout the study, participants will undergo extensive testing including blood, skin cell, urine, mouth swabs, and stool sample collections. Lung, smell, and skin health tests will be conducted at baseline and completion of each inpatient stay, with follow-up outpatient visits two weeks after each stay. Researchers will measure changes in skin impedance, gut microbiome diversity, airway resistance, inflammatory markers, quality of life, and other biological and activity parameters to evaluate the impact of environmental exposures over the course of the study.
CONDITIONS
THREAT: Testing Harms Related to Exposure to Allergenic and Epithelial Toxins
J
Jodi L Blake, R.N.
H
Hirsh D Komarow, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Product exposures with SLS, polyurethane, processed foods | Product exposures with SLS-free, toxin-free, minimally processed alternatives |
|---|---|---|
| What it is | A set of household products containing sodium lauryl sulfate (SLS), polyurethane, and processed foods—applied to airway, GI, or skin—designed to test exposure to potential allergens and toxins. | A set of corresponding household products that are SLS-free, toxin-free, and include a minimally processed diet, applied to the same organ systems as comparators. |
| Role in the study | Assesses the physiological and biological effects of exposure to allergenic and industrial toxins on the skin, airway, and GI tract. | Serves as the comparison group to distinguish the effects seen in the toxin-exposed arm by maintaining absence of known toxins and minimal processing. |
| Primary use in study | Testing the health and biological impact of environmental allergen and toxin exposures in healthy adults. | Evaluating reference values for physiological and biological responses in the absence of common environmental toxins. |
| How it is given or performed | Participants use standard household and dietary products containing SLS, polyurethane, and processed foods during inpatient stays assigned to airway, GI, or skin groups. | Participants use products that are SLS-free and toxin-free, along with a minimally processed diet, matching experimental product use but without added industrial toxins. |
| Evidence status | The health effects of common environmental products containing SLS, processed foods, and polyurethane remain under active study. Recent evidence links these exposures with epithelial barrier dysfunction and microbiome changes, but definitive clinical outcome data are limited. | Existing research suggests diets low in processed foods and reduced exposure to chemical agents may support a healthier gut and epithelial barrier in otherwise healthy adults, but long-term clinical outcome data remain emerging. |
| Important limitations | The study is experimental and short-term, with outcomes limited to changes in skin, airway, and GI measurements in the inpatient setting. Results may not capture chronic or cumulative health consequences. | The control arm follows strict toxin-free and minimally processed exposures not always replicable in real-world environments. Potential benefit or harm is only assessed within the short duration of the trial. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 7 days
Participants stay confined in a controlled environment for up to 7 days with assigned exposures, either to common environmental chemicals or a pure environment, following strict diet and personal care product use.
Daily assessments during stay
Duration - 4 to 6 weeks
Participants have a break of 4 to 6 weeks between inpatient stays to allow effects to normalize.
No visits required
Duration - 7 days
Participants have a second 7-day stay in the alternate environment from their first stay, continuing strict adherence to assigned diets and products with daily health assessments.
Daily assessments during stay
Duration - Up to 4 weeks
Participants attend outpatient visits approximately 2 weeks after each inpatient stay for repeat testing and monitoring of health changes.
2 follow-up visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
6
Have more questions? Get in touch with our team for quick support
Kevin Whelan, Aaron S Bancil, James O Lindsay...
https://pubmed.ncbi.nlm.nih.gov/38388570/Ismail Ogulur, Yagiz Pat, Tamer Aydin...
https://pubmed.ncbi.nlm.nih.gov/36464527/Yagiz Pat, Duygu Yazici, Paolo D'Avino...
https://pubmed.ncbi.nlm.nih.gov/38227765/Stanley P Galant, Hirsh D Komarow, Hye-Won Shin...
https://pubmed.ncbi.nlm.nih.gov/28583260/Arturo O Rinaldi, Angelica Korsfeldt, Siobhan Ward...
https://pubmed.ncbi.nlm.nih.gov/33830511/Marina Redruello-Requejo, María Del Mar Blaya, Daniel González-Reguero...
https://pubmed.ncbi.nlm.nih.gov/39940246/Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies...
https://pubmed.ncbi.nlm.nih.gov/36608129/Manoj Yadav, Prem Prashant Chaudhary, Brandon N D'Souza...
https://pubmed.ncbi.nlm.nih.gov/36877675/J Malvehy, A Hauschild, C Curiel-Lewandrowski...
https://pubmed.ncbi.nlm.nih.gov/24841846/Mari Sasaki, Mathilda Sundberg, Remo Frei...
https://pubmed.ncbi.nlm.nih.gov/37753955/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor